DinaAJacobsMD
Neurology • Philadelphia, PANeuroimmunology/Multiple Sclerosis
Associate Professor, Neurology, Perelman School of Medicine
Dr. Jacobs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce Street
2 Ravdin Building
Philadelphia, PA 19104Phone+1 215-662-3606
Education & Training
University of Pennsylvania Health SystemResidency, Neurology, 1997 - 2000- University of Pennsylvania Health SystemInternship, Internal Medicine, 1996 - 1997
Perelman School of Medicine at the University of PennsylvaniaClass of 1996
Certifications & Licensure
PA State Medical License 1997 - 2024- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) Start of enrollment: 2007 Mar 01
- Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis Start of enrollment: 2011 Mar 01
- Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- 139 citationsMacular Volume Determined by Optical Coherence Tomography as a Measure of Neuronal Loss in Multiple SclerosisBryn M. Burkholder, Benjamin Osborne, Michael J. Loguidice, Esther R. Bisker, Teresa C. Frohman
Archives of Neurology. 2009-11-09 - 475 citationsRelation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple SclerosisJennifer B. Fisher, Dina A. Jacobs, Clyde E. Markowitz, Steven L. Galetta, Nicholas J. Volpe
Ophthalmology. 2006-02-01 - 118 citationsCellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.Sokratis A. Apostolidis, Mihir Kakara, Mark M Painter, Rishi R. Goel, Divij Mathew
Nature Medicine. 2021-09-14
Press Mentions
Why Multiple Sclerosis Shouldn’t Discourage Women from Living Life on Their TermsMarch 16th, 2023- MS Diagnosis: What to Know About Tests and Treatments for Multiple SclerosisNovember 12th, 2021
Helping People Become Fascinated by Their Own BrainsMarch 16th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
